Clinical Trial 38351

Oakland, CA 94607


Summary:

A phase 2 study of MLR-1023 as an adjunctive treatment to metformin for Type 2 Diabetes.


Qualified Participants Must:

• Be between 18 and 75 years of age
• Be diagnosed with Type 2 Diabetes, and currently taking metformin


Qualified Participants May Receive:

Compensation for time and travel, may receive investigational medication and study related treatment at no cost.


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.